RACHEL COOK: Open Payments
NPI 1831748094 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,246 in 157 payments from 29 companies in 2025. Trend: 2023 $1,221 · 2024 $2,986 · 2025 $3,246
Food & beverage: $3,246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $588 |
| UCB, Inc. | 15 | $387 |
| PFIZER INC. | 17 | $227 |
| Novartis Pharmaceuticals Corporation | 11 | $216 |
| Neurelis, Inc. | 7 | $188 |
| Lundbeck LLC | 9 | $178 |
| ARGENX US, INC. | 4 | $151 |
| Neurocrine BioSciences, Inc. | 5 | $145 |
| SK Life Science, Inc. | 6 | $137 |
| Biogen, Inc. | 6 | $131 |
Products named: BOTOX, NURTEC ODT, KESIMPTA, VALTOCO, Rystiggo, Leqembi, Briviact, VYEPTI.
Industry payments across AL — which companies pay providers there.
